Monday, October 18, 2021 7:16:29 PM
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !
Recent VRDN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 01:00:13 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/18/2024 01:00:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/13/2024 10:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:25:59 PM
- Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock • Business Wire • 09/12/2024 03:25:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/10/2024 08:28:10 PM
- Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock • Business Wire • 09/10/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:11:01 AM
- Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease • Business Wire • 09/10/2024 11:00:00 AM
- Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024 • Business Wire • 09/09/2024 08:01:00 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/05/2024 08:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 08:06:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:25:01 PM
- Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:01:11 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/07/2024 08:01:00 PM
- Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) • Business Wire • 07/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:31:38 AM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/03/2024 12:00:00 PM
- Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease • Business Wire • 06/11/2024 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/10/2024 12:05:27 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/06/2024 08:01:00 PM
- Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences • Business Wire • 05/31/2024 12:00:00 PM
- Viridian Therapeutics to Participate in Upcoming May Investor Conferences • Business Wire • 05/10/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:51:21 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM